These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18513406)

  • 1. Cervical dysplasia and cancer and the use of hormonal contraceptives in Jamaican women.
    McFarlane-Anderson N; Bazuaye PE; Jackson MD; Smikle M; Fletcher HM
    BMC Womens Health; 2008 May; 8():9. PubMed ID: 18513406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depo medroxyprogesterone acetate (DMPA) and combined oral contraceptives and cervical carcinoma in-situ in women aged 50 years and under.
    Hoyo C; Cousins DS; Bisgrove EZ; Gaines MM; Schwingl PJ; Fortney JA
    West Indian Med J; 2004 Dec; 53(6):406-12. PubMed ID: 15816269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Masking effect of hormonal contraceptives on discriminating quantitative features of visually normal intermediate cells in positive and negative cervical smears.
    Kwikkel HJ; Boon ME; van Rijswijk MM; Rietveld WJ; Stolk JG
    Anal Quant Cytol Histol; 1986 Sep; 8(3):227-32. PubMed ID: 3778614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barrier methods of contraception and the risk of cervical neoplasia.
    Parazzini F; Negri E; La Vecchia C; Fedele L
    Contraception; 1989 Nov; 40(5):519-30. PubMed ID: 2692961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
    J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between hormonal contraception and cervical dysplasia/cancer controlling for human papillomavirus infection: A systematic review.
    Anastasiou E; McCarthy KJ; Gollub EL; Ralph L; van de Wijgert JHHM; Jones HE
    Contraception; 2022 Mar; 107():1-9. PubMed ID: 34752778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroidal contraceptives and bone fractures in women: evidence from observational studies.
    Lopez LM; Chen M; Mullins S; Curtis KM; Helmerhorst FM
    Cochrane Database Syst Rev; 2012 Aug; (8):CD009849. PubMed ID: 22895991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In utero exposure to steroid contraceptives and outcome of pregnancy.
    Pardthaisong T; Gray RH
    Am J Epidemiol; 1991 Oct; 134(8):795-803. PubMed ID: 1835282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrier and spermicidal contraceptive methods and risk of invasive cervical cancer.
    Hildesheim A; Brinton LA; Mallin K; Lehman HF; Stolley P; Savitz DA; Levine R
    Epidemiology; 1990 Jul; 1(4):266-72. PubMed ID: 2083303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptive use and cervical intraepithelial neoplasia.
    Coker AL; McCann MF; Hulka BS; Walton LA
    J Clin Epidemiol; 1992 Oct; 45(10):1111-8. PubMed ID: 1474407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.
    Roura E; Travier N; Waterboer T; de Sanjosé S; Bosch FX; Pawlita M; Pala V; Weiderpass E; Margall N; Dillner J; Gram IT; Tjønneland A; Munk C; Palli D; Khaw KT; Overvad K; Clavel-Chapelon F; Mesrine S; Fournier A; Fortner RT; Ose J; Steffen A; Trichopoulou A; Lagiou P; Orfanos P; Masala G; Tumino R; Sacerdote C; Polidoro S; Mattiello A; Lund E; Peeters PH; Bueno-de-Mesquita HB; Quirós JR; Sánchez MJ; Navarro C; Barricarte A; Larrañaga N; Ekström J; Lindquist D; Idahl A; Travis RC; Merritt MA; Gunter MJ; Rinaldi S; Tommasino M; Franceschi S; Riboli E; Castellsagué X
    PLoS One; 2016; 11(1):e0147029. PubMed ID: 26808155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of hormonal contraceptives in an institutional setting: reasons for use, consent and safety in women with psychiatric and intellectual disabilities.
    Egan TM; Siegert RJ; Fairley NA
    N Z Med J; 1993 Aug; 106(961):338-41. PubMed ID: 8341476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription contraceptives: countering the risks.
    Ruggiero RJ
    Am Pharm; 1985 Sep; NS25(9):32-7. PubMed ID: 4050670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical neoplasia risk in women provided hormonal contraception without a Pap smear.
    Sawaya GF; Harper C; Balistreri E; Boggess J; Darney P
    Contraception; 2001 Feb; 63(2):57-60. PubMed ID: 11292467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contraception in the adolescent patient.
    Tafelski T; Boehm KE
    Prim Care; 1995 Mar; 22(1):145-59. PubMed ID: 7777635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility following discontinuation of different methods of fertility control.
    Fraser IS; Weisberg E
    Contraception; 1982 Oct; 26(4):389-415. PubMed ID: 6759030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
    Myer L; Denny L; Wright TC; Kuhn L
    Int J Epidemiol; 2007 Feb; 36(1):166-74. PubMed ID: 17175547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
    Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK
    Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative and attributable risk for cervical cancer: a comparative study in the United States and Italy.
    Parazzini F; Hildesheim A; Ferraroni M; La Vecchia C; Brinton LA
    Int J Epidemiol; 1990 Sep; 19(3):539-45. PubMed ID: 2135870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of cervical dysplasia in users of oral contraceptives, intrauterine devices or depot-medroxyprogesterone acetate. The New Zealand Contraception and Health Study Group.
    Contraception; 1994 Nov; 50(5):431-41. PubMed ID: 7859452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.